Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 540 | 900 | 570 | 60 | 220 |
| TOTAL | $540 | $900 | $570 | $60 | $220 |
| Non-Current Assets | |||||
| PPE Net | 470 | 750 | 1,150 | 380 | 460 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $470 | $750 | $1,150 | $380 | $470 |
| Total Assets | $1,010 | $1,650 | $1,720 | $440 | $690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,010 | 2,920 | 1,380 | 1,150 | 1,290 |
| Accrued Expenses | 4,530 | 3,340 | 3,930 | 2,360 | 2,750 |
| Other current liabilities | 1,250 | 2,500 | 0 | 430 | 500 |
| TOTAL | $7,790 | $8,760 | $5,310 | $3,940 | $4,540 |
| Non-Current Liabilities | |||||
| TOTAL | $40 | $60 | $70 | $N/A | $N/A |
| Total Liabilities | $7,830 | $8,820 | $5,380 | $3,940 | $4,540 |
| Shareholders' Equity | |||||
| Common Shares | 110 | 100 | 100 | 100 | 80 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -10 |
| TOTAL | $81,110 | $76,810 | $74,130 | $72,460 | $57,910 |
| Total Liabilities And Equity | $88,940 | $85,630 | $79,510 | $76,400 | $62,450 |